Work

Loss of p53 and altered miR15-a/16-1→MCL-1 pathway in CLL: insights from TCL1-Tg:p53−/− mouse model and primary human leukemia cells

Year: 2013

Type: article

Source: Leukemia

DOI: 10.1038/leu.2013.125

Authors: J Liu, G Chen, L Feng, W Zhang, H Pelicano, F Wang, M A Ogasawara, W Lu, H M Amin, C M Croce, M J Keating, P Huang

Institutions: The University of Texas MD Anderson Cancer Center, First Affiliated Hospital of Nanchang University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, The Ohio State University Wexner Medical Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: CLL Global Research Foundation, National Institutes of Health, National Cancer Institute

Awards: G1857060636, G1901027039, ROS, Redox Regulation and Novel Targets for Cancer Therapy, Novel Roles of p53 & ROS in Therapy of Refractory CLL, G7630657119, Chronic Lymphocytic Leukemia Research Consortium, TOWARD AN UNDERSTANDING OF CLL PROGRESSION, Cancer Center Support Grant, G944802235

OpenAlex ID: W2025965695

FWCI: 3.939

Cites: 44

Cited by: 59

Related to: 10